Clinical Trial Update: CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction

View source ↗

Summary

The Medtronic-sponsored CARISMA study on cardiac arrhythmias and risk stratification after acute myocardial infarction has completed, with results posted on 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Acute Myocardial Infarction | Status: COMPLETED | Results posted: 2014-01-17